ConductScience.org, home

Paper3127076

Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris.

Horowitz JD and 6 others. Circulation, 1988. Cited by 94 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris. Papers, record 3127076. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3127076

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris.
PubMed
Journal
Circulation
PubMed
Year
1988
PubMed
Publication types
Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
94
iCite
Relative citation ratio, by iCite
3.16
iCite
Revised in PubMed
2019-06-23
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Horowitz JDJ D
2Henry CAC A
3Syrjanen MLM L
4Louis WJW J
5Fish RDR D
6Smith TWT W
7Antman EME M

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcetylcysteineMajor topic
Angina PectorisMajor topic
Angina, UnstableMajor topic
NitroglycerinMajor topic
Clinical Trials as Topic
Double-Blind Method
Drug Therapy, Combination
Female
Humans
Hypotension
Male
Myocardial Infarction
Random Allocation
Risk Factors

Source PubMed

Download CSV of topics

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 94 citations.

PMIDTitleJournalYearIn PapersSource
38136193N-Acetylcysteine and Atherosclerosis: Promises and Challenges.Antioxidants (Basel)2023https://conductscience.org/library/papers/38136193PubMed
37005695
Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania.
Pilot Feasibility Stud2023https://conductscience.org/library/papers/37005695PubMed
34727343Oral N-acetylcysteine as an adjunct to standard medical therapy improved heart function in cases with stable class II and III systolic heart failure.Ir J Med Sci2022https://conductscience.org/library/papers/34727343PubMed
34208683N-Acetylcysteine (NAC): Impacts on Human Health.Antioxidants (Basel)2021https://conductscience.org/library/papers/34208683PubMed
33048324Progression of heart failure is attenuated by antioxidant therapy with N-acetylcysteine in myocardial infarcted female rats.Mol Biol Rep2020https://conductscience.org/library/papers/33048324PubMed
31857574Mitochondrial dysfunction and oxidative stress in heart disease.Exp Mol Med2019https://conductscience.org/library/papers/31857574PubMed
23436032Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants.Heart Fail Rev2014https://conductscience.org/library/papers/23436032PubMed
16440146Effect of N-acetylcysteine on oxidative stress and ventricular function in patients with myocardial infarction.Heart Vessels2006https://conductscience.org/library/papers/16440146PubMed
16187967Preservation of platelet responsiveness to nitroglycerine despite development of vascular nitrate tolerance.Br J Clin Pharmacol2005https://conductscience.org/library/papers/16187967PubMed
12652159Nitric oxide, platelet function, myocardial infarction and reperfusion therapies.Heart Fail Rev2003https://conductscience.org/library/papers/12652159PubMed
11444642N-acetylcysteine improves microcirculatory flow during smoking: new effects of an old drug with possible benefits for smokers.Clin Cardiol2001https://conductscience.org/library/papers/11444642PubMed
10651168Effects of N-acetylcysteine on nitroglycerin-induced relaxation and protein phosphorylation of porcine coronary arteries.Heart Vessels1998https://conductscience.org/library/papers/10651168PubMed
7947366Mechanisms of nitrate tolerance.Cardiovasc Drugs Ther1994https://conductscience.org/library/papers/7947366PubMed
7873468Nitrates for unstable angina.Cardiovasc Drugs Ther1994https://conductscience.org/library/papers/7873468PubMed
7729327Nitrate tolerance in angina therapy. How to avoid it.Drugs1995https://conductscience.org/library/papers/7729327PubMed
7531993Inhibition of platelet aggregation by transdermal glyceryl trinitrate.Br Heart J1994https://conductscience.org/library/papers/7531993PubMed
2661197Nitrate tolerance. A review of the evidence.Drugs1989https://conductscience.org/library/papers/2661197PubMed
2598989The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage.Eur J Clin Pharmacol1989https://conductscience.org/library/papers/2598989PubMed
2511992S-nitrosothiols as vasodilators: implications regarding tolerance to nitric oxide-containing vasodilators.Br J Pharmacol1989https://conductscience.org/library/papers/2511992PubMed
2503018Glyceryl trinitrate and platelet aggregation: effects of N-acetyl-cysteine.Br J Clin Pharmacol1989https://conductscience.org/library/papers/2503018PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3127076

GET https://conductscience.org/api/papers/v1/3127076/cited_by?page=2